Last reviewed · How we verify
NCT03063112: RF
Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain
NA trial testing Radiofrequency generator device in Abdominal Cancer in 79 participants. Status unknown.
10 April 2017
Quick facts
| Lead sponsor | South Egypt Cancer Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 79 |
| Start date | 1 October 2016 |
| Primary completion | 10 April 2017 |
| Estimated completion | 1 May 2017 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Radiofrequency generator device
- Lidocaine — full drug profile →
- C arm fluoroscopic device
- Ethyl alcohol — full drug profile →
Conditions studied
- Abdominal Cancer — all drugs for Abdominal Cancer →
Sponsor
South Egypt Cancer Institute
Who can join
Adults 18 to 70, any sex, with Abdominal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study compares between the efficacy, safety and impact on the quality of life of radiofrequency thermocoagulation and chemical neurolysis of bilateral thoracic splanchnic nerves in the management of refractory pain which developed in patients suffering from upper abdominal cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03063112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abdominal Cancer
Currently open trials in the same condition.
- NCT05903430 — A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION) · recruiting
- NCT05219058 — Reconstruction in Extended MArgin Cancer Surgery · recruiting
- NCT00493688 — A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes · recruiting
Other South Egypt Cancer Institute trials
Trials by the same sponsor.
- NCT07438366 — Adding Magnesium Sulphate to Combined Pectointercostal Plane and Erector Spinae Plane Blocks for Acute and Chronic Post- · NA · not yet recruiting
- NCT07434232 — Adding Magnesium Sulfate to Combined Pecto-Intercostal & Serratus Anterior Planes Block on Post-operative Analgesia in P · NA · not yet recruiting
- NCT07434206 — Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors · Phase 2, PHASE3 · active not recruiting
- NCT05279378 — Correlation of Lung Ultrasonography With Chest CT Findings in Cancer Patients With COVID-19 Viral Pneumonia · completed
- NCT05587608 — US-guided Thoracic Spinal Epidural Anesthesia VS GA for Abdominal and Breast Surgeries · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03063112 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by South Egypt Cancer Institute
- Last refreshed: 28 February 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03063112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing